Business Update Positive

2026-08-28 08:54

- Acutaas Chemicals' step-down subsidiary Indichem Inc. inaugurated its semiconductor materials plant in Gongju, South Korea, on August 28, 2026. - The plant, completed in 11 months, involves an investment of approximately ₹200 crore and will synthesize chemicals in India for refinement in South Korea, targeting the semiconductor industry.

Governance Positive

2026-08-22 17:37

- Board approved the 19th AGM on Sep 24, 2026, and adopted FY26 Annual Report. - Re-appointed Mr. Ram Mohan Lokhande as Whole Time Director and Mrs. Anita Bandyopadhyay as Independent Director for five years from Feb 8, 2027. - Approved ₹212 Cr capex for a new electronic grade chemicals plant in Gujarat (81,000 MT/annum by FY28).

Business Update Positive

2026-08-18 10:55

- Acutaas Chemicals Limited received approval for an incentive package under the Electronic Components Manufacturing Scheme (ECMS) from the Ministry of Electronics and Information Technology (MeitY). - The approval is for the Company's Electrolyte Additives manufacturing business. - The eligible investment for the ECMS incentive scheme is ₹119.12 crores, with an expected incentive benefit of up to 25% of the eligible investment, valid until FY 2030-31.

Business Update Neutral

2026-08-08 12:56

- Investor Conferences/Meets Schedule - August 12, 2026: Nuvama 21st India Investor Conference in Singapore - August 13, 2026: Equirus India Growth Summit in Mumbai

Business Update Positive

2026-07-28 18:26

- Management reaffirmed guidance of 25% revenue growth for FY27 with stable margins, similar to FY26 levels. - Advanced Pharmaceutical Intermediates segment is performing robustly, with a strong CDMO and NCE product pipeline. The company is confident in achieving its INR1,000 Cr revenue target from CDMO business by FY28. - Battery chemicals plant has commenced commercial supply, experiencing unprecedented demand and expecting rapid ramp-up to full capacity utilization by FY29. - The Indichem plant for semiconductor chemicals is ahead of schedule, with revenue anticipated from next financial year onwards and full capacity utilization expected in 3-4 years. - The company is strategically phasing out lower-margin commodity chemicals to focus on higher-margin specialty products. - FY27 capex is estimated at INR50 Cr for electrolyte additives/pilot plant and INR40-45 Cr for maintenance, with further capex for R&D and land acquisition to be announced.

Business Update Neutral

2026-07-24 18:25

- The recording of the Earnings Call held on July 24, 2026, at 4:00 p.m. IST is now available. - The recording can be accessed on the company's website (www.acutaas.com) and via the provided direct link.

Financials Positive

2026-07-24 13:02

- Consolidated Revenue ₹3,297 Mn vs ₹2,072 Mn (▲59.1% YoY) - EBITDA ₹1,131 Mn vs ₹509 Mn (▲122.1% YoY) - PAT ₹750 Mn vs ₹440 Mn (▲70.4% YoY) - EBITDA Margin 34.3% vs 24.6% (▲970bps) - Management expects 25% revenue growth for the full year with stable margins.

Financials Negative

2026-07-24 12:33

CRITICAL RED FLAG DETECTED

- Consolidated Revenue ₹32,967.48 lakhs vs ₹20,723.72 lakhs (▲59.1% YoY) - EBITDA ₹11,307.11 lakhs vs ₹5,090.73 lakhs (▲122.1% YoY) - PAT ₹7,499.27 lakhs vs ₹4,401.05 lakhs (▲70.4% YoY) - EBITDA Margin 34.29% vs 24.56% (▲973bps) - Regulatory inspection/search by CGST & CE Anti-Evasion Department concluded with management expecting no material impact.

Business Update Neutral

2026-07-20 11:47

- Concall Schedule - Concall Date: July 24, 2026 - Concall Time: 4:00 P.M. IST - Purpose: To discuss Q1FY27 Unaudited Financial Results.

Governance Neutral

2026-07-02 20:25

- Acutaas Chemicals Limited announced the promotion and designation of Mr. Anurag Shukla as General Manager Operations & Unit Head - Ankleshwar. - He is designated as a Senior Management Personnel of the company, effective July 2, 2026.

Ownership Neutral

2026-06-26 17:41

- Trading Window for Designated Persons to close from July 1, 2026, for the purpose of considering Unaudited Financial Results for the first quarter ended June 30, 2026. - The window will reopen 48 hours after the declaration of the results.

Business Update Negative

2026-06-23 11:24

CRITICAL RED FLAG DETECTED

- Acutaas Chemicals Limited announced the conclusion of an Inspection/Search by the Central Goods & Service Tax & Central Excise (CGST & CE), Anti-evasion Department, Surat, on June 23, 2026.- The company stated there is no material impact on its financials, operations, or other activities due to this inspection.

Business Update Negative

2026-06-22 21:27

CRITICAL RED FLAG DETECTED

- CGST & CE, Anti-evasion Department initiated inspection/search proceedings at the company's Sachin facility and registered office on June 22, 2026. - The proceedings are ongoing, and the company is cooperating. - Currently, there is no material impact on financials or operations.

Ownership Positive

2026-05-19 18:23

Acutaas Chemicals Limited announced on May 19, 2026, the preferential allotment of 1,111 equity shares of its subsidiary, Acutaas Chemicals Electrolytes Private Limited (ACEPL), to A.R.Z Pharma Ltd. at an issue price of Rs. 52,490/- per share. This transaction reduces Acutaas Chemicals Limited's shareholding in ACEPL from 100% to 90%, transitioning ACEPL from a wholly-owned subsidiary to a subsidiary. Management control of ACEPL remains unchanged with Acutaas Chemicals Limited.

Business Update Neutral

2026-05-14 18:17

ACUTAAS CHEMICALS LIMITED announced its schedule of investor conferences for May and June 2026. Company officials will attend the 360 ONE Capital (B&K) 16th Annual Investor Conference - Trinity India 2026 in Mumbai on May 27 & 29, and Kotak India Corporate Day events in Hongkong (June 8), Singapore (June 9 & 10), and London (June 15 & 16) to interact with investors/analysts. No price-sensitive information will be discussed.

Routine Neutral

2026-05-06 10:46

New Filing detected. See link for details.

Business Update Neutral

2026-04-30 19:19

ACUTAAS CHEMICALS LIMITED informed the stock exchanges about the availability of the recording for its Earnings Call, which was held on April 30, 2026, at 5:30 p.m. IST. The recording can be accessed on the company's website at www.acutaas.com and through a direct link provided in the filing.

Routine Neutral

2026-04-30 17:38

New Filing detected. See link for details.

Financials Positive

2026-04-30 12:40

Acutaas Chemicals Limited reported strong Q4 FY26 consolidated results. Revenue from Operations stood at ₹4,328mn vs ₹3,085mn (▲40.3% YoY), EBITDA at ₹1,835mn vs ₹850mn (▲116.0% YoY), and PAT at ₹1,343mn vs ₹627mn (▲114.1% YoY). EBITDA Margin expanded significantly to 42.4% vs 27.5% (▲1490bps). Management is confident of delivering 25% revenue growth in FY27.

Financials Positive

2026-04-30 12:25

ACUTAAS CHEMICALS LIMITED (formerly Ami Organics Limited) reported strong consolidated financial results for the quarter ended March 31, 2026. Consolidated Revenue stood at ₹432.75 Cr compared to ₹308.48 Cr in the previous year's corresponding quarter, marking a significant ▲40.26% YoY growth. EBITDA surged to ₹183.51 Cr versus ₹84.96 Cr (▲116.00% YoY), and Net Profit (PAT) increased to ₹134.28 Cr from ₹62.72 Cr (▲114.11% YoY). The company also saw a substantial EBITDA Margin expansion from 27.54% to 42.40% (▲1486 bps). Additionally, the Board recommended a final dividend of ₹2.50 per equity share (50%) for FY 2025-26.

Business Update Neutral

2026-04-27 14:31

Acutaas Chemicals Limited announced an Earnings Conference Call on April 30, 2026, at 5:30 P.M. IST, to discuss the Audited Standalone & Consolidated Financial Results for the fourth quarter and year ended March 31, 2026.

Routine Neutral

2026-04-08 12:10

New Filing detected. See link for details.

Routine Neutral

2026-04-02 18:10

Acutaas Chemicals Limited filed a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent confirmed no dematerialisation requests were received or processed during the quarter.

Routine Neutral

2026-03-25 16:21

Acutaas Chemicals Limited announced the closure of its trading window for designated persons from April 1, 2026, for the purpose of considering the audited financial results for the fourth quarter and year ending March 31, 2026. The window will reopen 48 hours after results declaration.

Business Update Neutral

2026-03-02 12:01

Acutaas Chemicals Limited announced its officials will attend the Investec India Promoter & Founder Conference 2026 on March 11, 2026, in Mumbai. They will engage with investors/analysts in one-on-one or group meetings. No unpublished price-sensitive information will be discussed during the conference.

Business Update Neutral

2026-02-17 12:33

Acutaas Chemicals Limited announced that company officials will attend the Omkara Capital Investors Meet on February 21, 2026, and the Kotak Flagship Conference on February 24, 2026, for one-on-one/group meetings with investors and analysts. No unpublished price-sensitive information will be discussed.

Business Update Positive

2026-02-11 19:03

Acutaas Advance Material Limited, a subsidiary of Acutaas Chemicals Limited, completed the acquisition of a 75% controlling stake in Indichem Inc., a South Korean company in the Semiconductor Chemicals industry. This acquisition aligns with the company's growth strategy to expand its specialty chemicals portfolio.

Business Update Positive

2026-02-03 14:57

Acutaas Chemicals Limited Q3 FY26 Earnings Call transcript confirms strong performance. Revenue just under INR400Cr, PAT over INR100Cr, with YoY growth of 47% in Advanced Pharma and 16.5% in Specialty Chemicals. FY26 revenue growth guidance upgraded to 30%, EBITDA margin to 32-35%. New battery chemicals block inaugurated.

Business Update Neutral

2026-01-30 17:59

Acutaas Chemicals Limited officials will attend the JM Financial India Xchange Conference on February 5, 2026, in Singapore for one-on-one/group meetings with investors/analysts.

Business Update Positive

2026-01-29 18:36

Acutaas Chemicals Limited filed its Annual Sustainability Report for FY 2024-25. The company reported surpassing ₹1,000 crore in consolidated revenue and achieving the EcoVadis Platinum Medal, demonstrating strong financial and sustainability performance.

Financials Positive

2026-01-29 18:21

Consolidated Revenue ₹393.18Cr vs ₹274.99Cr (▲43.0% YoY), EBITDA ₹155.35Cr vs ₹70.34Cr (▲120.9% YoY), PAT ₹106.22Cr vs ₹45.45Cr (▲133.7% YoY). EBITDA Margin 39.5% vs 25.6% (▲1393bps).

ACUTAAS

Acutaas Chemicals Limited

Price Chart

Filing History

Unlock Full History